To utilize the BioAMS User Facility, investigators should first discuss their interest with the staff. For initial contact with the User Facility for referral to scientific staff or other information such as submitting applications, please contact:
After discussion of the research problem with User Facility staff, investigators need to submit a application outlining the scientific problem and their proposed experiments (see Application and Review). Applications are accepted at any time. Before a final decision for inclusion in the User Facility is made, applications will be reviewed to make sure the research problem is appropriate for AMS.
All research proposals utilizing Human Subjects and/or Vertebrate Animals must conform to the NIH Human Subjects Research regulations and Animal use guidelines. The use of Human Subjects or Vertebrate Animals should be discussed with the User Facility staff prior to submitting an application. Applicants must be able to provide documentation of Institutional approval for the use of Human Subjects and/or Vertebrate Animal in proposed research studies.
The User Facility can be utilized by biomedical researchers for either single experimental projects or program projects that describe a series of intellectually linked experiments. Although investigators do not need to have NIH funding to utilize the User Facility, priority will be given to research projects that are NIH funded.
Researchers proposing to perform AMS research need to evaluate their laboratories and equipment for background isotope levels that might interfere with their studies. The specific number and type of samples needed for QA/QC purposes will be determined in consultation with the User Facility staff.
The number of AMS measurements supported at no fee will be determined in discussion with the proposal principal investigator. The supported measurements should allow for the completion of most projects. Use of the AMS User Facility above the number of supported samples is possible for a nominal per sample measurement fee via a cost recovery measurement agreement with LLNL.